Table 1.
Baseline characteristics | Patients, n = 22 (%) |
---|---|
Gender | |
Male | 6 (27.3) |
Female | 16 (72.7) |
Age | |
Mean ± SD | 63.4 ± 13.3 |
Liver cirrhosis | |
Yes | 8 (36.4) |
No | 14 (63.6) |
Autoimmune liver disease | |
Autoimmune hepatitis | 4 (18.2) |
Primary biliary cholangitis | 12 (54.5) |
Primary sclerosing cholangitis | 5 (22.7) |
Variant syndrome AIH-PSC | 1 (4.5) |
Other autoimmune disease | |
Autoimmune hemolytic anemia | 1 (4.5) |
Autoimmune thyroiditis | 1 (4.5) |
Rheumatoid arthritis | 1 (4.5) |
Sjögren syndrome | 1 (4.5) |
Ulcerative colitis | 2 (9.1) |
None | 17 (77.3) |
Tumor type | |
Hepatobiliary cancer | 11 (50.0) |
Non hepatobilary cancer | 11 (50.0) |
Liver metastases present | 2 (9.1) |
No liver metastases present | 9 (40.9) |
The following tumor diseases were registered: Hepatocellular cancer (n=6), biliary tract cancer (n=5), non-small cell lung cancer (n=4), malignant melanoma (n=2), breast cancer (n=1), esophageal cancer (n=1), small cell lung cancer (n=1), renal cell cancer (n=1), and head and neck cancer (n=1).